Items where authors include "Rees, C.J."
Article
Sun, G., Fuller, H., Fenton, H. et al. (7 more authors) (2024) The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E2 synthesis and platelet activation in participants of the seAFOod polyp prevention trial. International Journal of Cancer, 154 (5). pp. 873-885. ISSN 0020-7136
Davies, J.R. orcid.org/0009-0002-4272-2477, Mell, T. orcid.org/0009-0001-6744-1340, Fuller, H. orcid.org/0000-0001-8381-519X et al. (10 more authors) (2023) Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial. Cancer Prevention Research, 16 (11). pp. 621-630. ISSN 1940-6207
Davies, J.R. orcid.org/0009-0002-4272-2477, Mell, T. orcid.org/0009-0001-6744-1340, Fuller, H. orcid.org/0000-0001-8381-519X et al. (10 more authors) (2023) Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial. Cancer Prevention Research, 16 (11). pp. 621-630. ISSN 1940-6207
Sun, G., Fuller, H., Fenton, H. et al. (7 more authors) (2023) The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E2 synthesis and platelet activation in participants of the seAFOod polyp prevention trial. International Journal of Cancer. ISSN 0020-7136
Downing, A. orcid.org/0000-0002-0335-7801, Fenton, H., Nickerson, C. et al. (6 more authors) (2023) Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short-term aspirin use. Alimentary Pharmacology and Therapeutics, 58 (6). pp. 562-572. ISSN 0269-2813
Downing, A., Fenton, H., Nickerson, C. et al. (6 more authors) (2023) Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: evidence of rebound elevated colorectal polyp risk after short-term aspirin use. Alimentary Pharmacology & Therapeutics. ISSN 0269-2813
Fuller, H., Race, A.D., Fenton, H. et al. (7 more authors) (2023) Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial. Prostaglandins, Leukotrienes and Essential Fatty Acids, 192. 102570. ISSN 0952-3278
Fuller, H., Race, A.D., Fenton, H. et al. (7 more authors) (2023) Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial. Prostaglandins, Leukotrienes and Essential Fatty Acids, 192. 102570. ISSN 0952-3278
Rutter, M.D., East, J., Rees, C.J. et al. (19 more authors) (2019) British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. Gut, 69 (2). pp. 201-223. ISSN 0017-5749
Hull, M.A., Sprange, K., Hepburn, T. et al. (10 more authors) (2018) Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial. Lancet, 392 (10164). pp. 2583-2594. ISSN 0140-6736